DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-13 10:01:34 ET
DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call Transcript
DiaMedica Therapeutics Inc.
NASDAQ: DMAC
DMAC Trading
0.34% G/L:
$7.68 Last:
41,483 Volume:
$7.54 Open:
DMAC Latest News
March 05, 2026 07:35:00 am
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
February 24, 2026 09:23:00 am
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
January 16, 2026 05:00:00 pm
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2025 08:45:00 am
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
DMAC Stock Data
$439,533,585
29,684,140
16.95%
29
N/A
Biotechnology & Life Sciences
Healthcare
US
Minneapolis
